OMCL: Rasio silihan jangka dawa marang modal omnicell.com

Lambang korporat lan logo Omnicell Health (OMCL)

The price trajectory of Omnicell, Inc. (OMCL) reflects the dynamics of a company specializing in pharmacy robotics, where the indicator stands at 0.14. The business relies on third-party hardware assemblers while maintaining internal control over the software. The automation of production lines is complemented by high-end engineers working on dispensing systems. Currently, updated management is restructuring operational processes, gradually regaining market confidence by stabilizing demand.

Omnicell Corp (OMCL) - Utang jangka dawa marang ekuitas saka 04.07.2022 nganti 30.10.2026
Produk asli Omnicell Inc

Scaling the network of smart pharmacy cabinets and the transition of Omnicell, Inc. (OMCL) to cloud-based SaaS control require significant capital expenditures, as reflected in the long-term debt-to-equity chart. This indicator compares liabilities with maturities exceeding one year against shareholders' equity, allowing investors to assess the degree of financial leverage and the sustainability of the debt load during the long-term development of the business.

Analisis perusahaan pesaing

Veeva Systems (VEEV) - Rasio tanggungan utang jangka dawa marang modal|Rasio utang jangka dawa marang ekuitas DOCS (Doximity Corp)|Rasio silihan jangka dawa marang modal HQY|Waystar Holding Corp. - Rasio utang jangka dawa marang ekuitas|Koefisien utang jangka dawa marang modal CRVL|PRVA - Utang jangka dawa marang ekuitas|Huron Consulting Group Inc. (HURN) - Rasio utang jangka dawa marang ekuitas|CERT: Utang jangka dawa marang modal|Kewajiban jangka dawa marang modal GoodRx Gold (GDRX)|SDGR (Schrodinger, Inc.) - Utang jangka dawa marang modal|Rasio utang jangka dawa marang modal PHR (phreesia.com)|Utang jangka dawa marang ekuitas Omada Health (OMDA)|EVH - Kewajiban jangka dawa marang modal|Utang jangka dawa marang ekuitas HealthStream Corp HSTM|DH - Rasio utang jangka dawa marang ekuitas|CCSI - Utang jangka dawa marang ekuitas|AGL (agilonhealth.com) - Rasio utang jangka dawa marang modal|ABSI: Utang jangka dawa marang modal|SY - Rasio tanggungan utang jangka dawa marang modal|NRC (National Research) - Utang jangka dawa marang modal|Rasio utang jangka dawa marang ekuitas USA Mobility (SPOK)|Utang jangka dawa marang modal OPRX|TBRG - Kewajiban jangka dawa marang modal|Utang jangka dawa marang ekuitas Simulations Plus SLP|Sophia Genetics - Utang jangka dawa marang ekuitas|HCAT - Utang jangka dawa marang ekuitas|CCLD: Utang jangka dawa marang ekuitas|RSSS (Research Solutions) - Rasio utang jangka dawa marang ekuitas|DLH Holdings - Koefisien utang jangka dawa marang modal|ONMD (OneMedNet Corp) - Utang jangka dawa marang modal|Scienture Holdings (SCNX) - Rasio tanggungan utang jangka dawa marang modal|Utang jangka dawa marang ekuitas Healthcare Triangle Corp (HCTI)|ispecimen.com - Rasio utang jangka dawa marang modal|Utang jangka dawa marang modal BFRG (Bullfrog AI)|WORX - Rasio utang jangka dawa marang ekuitas|MSPR: Rasio utang jangka dawa marang ekuitas|Rasio tanggungan utang jangka dawa marang modal iCoreConnect Inc. ICCT|TRxADE (MEDS) - Utang jangka dawa marang ekuitas|Kewajiban jangka dawa marang modal Orgenesis Corporation (ORGS)|Utang jangka dawa marang ekuitas R1 RCM, Inc.|Rasio utang jangka dawa marang ekuitas sharecare.com (SHCR)|Utang jangka dawa marang modal STRM|Rasio utang jangka dawa marang ekuitas Syra Health Corp SYRA|Utang jangka dawa marang ekuitas Apollo Medical Holdings, Inc. AMEH|Model N Corporation - Utang jangka dawa marang ekuitas|NextGen Healthcare - Utang jangka dawa marang modal